Phone: +62-21 22116225 | Information@seameo-recfon.org
Biochemical Assessment
What is biochemical assessment?
Biochemical assessment is a laboratory-based evaluation that measures nutrient levels, metabolites, and key biochemical markers in biological samples.
Why is biochemical assessment important?
Biochemical assessment delivers reliable, quantitative data that cannot be obtained through observation alone. These results support the detection of nutrient deficiencies or excesses, guide clinical and nutritional interventions, and generate evidence that contributes to better health planning and public nutrition policies. Our laboratory ensures high-quality testing to support informed decision-making for both individuals and programs.
Our Services:
Description
Retinol is the main circulating form of vitamin A, released from the liver with retinol-binding protein and essential for vision, epithelial integrity, and gene regulation. Serum retinol reflects liver vitamin A stores only when they are very low (<0.07 µmol/g liver) or very high (>1.05 µmol/g liver); within the normal range, concentrations are homeostatically regulated and may not indicate dietary intake or early deficiency in individuals.
At the population level, the distribution of serum retinol values, and the proportion falling below established cut-offs, can help identify whether vitamin A deficiency is a public health concern. Testing is commonly conducted among young children, who are most vulnerable. Vitamin A deficiency increases susceptibility to infections, raises childhood mortality risk, and remains the leading preventable cause of childhood blindness worldwide.
Useful for
Method
High Preasure Liquid Cromatography (HPLC) with UV detection (MU.7.2.3)
Lower Limit of Quantitation (LLOQ): 0.293 µmol/L
Sample Requirements
Sample type:
Patient preparation:
Sample volume: 200 µL
Sample Handling and Preparation
Sample stability:
Quality Control (QC)
Reference Values
Deficient: < 0.70 µmol/L
Low: < 1.05 µmol/L
Acceptable: ≥ 1.05 µmol/L
Turnaround Time
Results are available within 14 working days for up to 160 samples. For larger batches, please contact the laboratory team.
References
*) Accredited by KAN 17025:2017
For more information please contact:
lab@seameo-recfon.org
Description
Vitamin E contributes to the normal maintenance of biomembranes the vascular system, and the nervous system, and provides antioxidant protection for vitamin A. The level of vitamin E in the plasma or serum after a 12- to 14-hour fast reflects the individual’s reserve status.
Currently, the understanding of the specific actions of vitamin E is very incomplete. The tocopherols (vitamin E and related fat-soluble compounds) function as antioxidants and free-radical scavengers, protecting the integrity of unsaturated lipids in the biomembranes of all cells and preserving retinol from oxidative destruction. Vitamin E is known to promote the formation of prostacyclin in endothelial cells and to inhibit the formation of thromboxanes in thrombocytes, thereby minimizing the aggregation of thrombocytes at the surface of the endothelium. Those influences on thrombocyte aggregation may be of significance in relation to risks for coronary atherosclerosis and thrombosis.
Useful for
Method
High-Performance Liquid Chromatography (HPLC) with UV detection (MU.7.2.4)
Limit of Quantitation (LOQ): 7.163 µmol/L
Sample Requirements
Sample type:
Patient preparation:
Sample volume: 200 µL
Sample Handling and Preparation
Sample stability:
Quality Control (QC)
Reference Values
Deficient: < 11.6 µmol/L
Low: 11.6–16.2 µmol/L
Acceptable: ≥ 16.2 µmol/L
Turnaround Time
Results are available within 14 working days for up to 160 samples. For larger batches, please contact the laboratory team.
References
*) Accredited by KAN 17025:2017
For more information please contact:
lab@seameo-recfon.org
Description
β-Carotene is a provitamin A carotenoid and an essential dietary nutrient found in many fruits and vegetables, contributing to their characteristic orange pigmentation. In the body, excess β-carotene is stored mainly in adipose tissue. High intake may lead to carotenodermia, a harmless condition characterized by orange discoloration of the skin. β-Carotene deficiency can occur in individuals with poor dietary intake or conditions that impair fat absorption, including cystic fibrosis, chronic pancreatic disorders (such as pancreatitis or pancreatic insufficiency), and malabsorption syndromes such as celiac disease.
Useful for
Method
High-Performance Liquid Chromatography (HPLC)
Limit of Quantitation (LOQ): 0.133 µmol/L
Sample Requirements
Sample type:
Patient preparation:
Sample volume:
Sample Handling and Preparation
Sample stability:
Quality Control (QC)
Reference Values
Normal: 0.3–0.6 µmol/L
Turnaround Time
Results are available within 14 working days for up to 160 samples. For larger batches, please contact the laboratory team.
References
*) Accredited by KAN 17025:2017
For more information please contact:
lab@seameo-recfon.org
Description
Serum zinc is the primary biochemical indicator for assessing zinc deficiency at the population level. It reflects dietary zinc intake and responds consistently to zinc supplementation, making it useful for identifying populations or subgroups at higher risk of deficiency. Although reference data exist for most age and sex groups, serum zinc cannot be used to diagnose or treat zinc deficiency in individuals, as circulating zinc does not directly represent total body zinc status.
Serum zinc concentrations are influenced by multiple factors, including recent meals, time of day, age, sex, hormonal contraceptive use, inflammation, and systemic infections. Because inflammation can depress serum zinc levels, the International Zinc Nutrition Consultative Group (IZiNCG) recommends measuring inflammatory markers together with zinc and applying statistical adjustments when significant negative correlations are observed.
Useful for
Method
Atomic Absorption Spectrophotometry/AAS (MU.7.2.2)
Lower Limit of Quantitation (LLOQ): 4.03 µmol/L
Upper Limit of Quantitation (ULOQ): 60.63 µmol/L
Sample Requirements
Sample type:
Patient preparation:
Sample volume:
Sample Handling and Preparation
To minimize zinc contamination:
Sample stability:
Quality Control (QC)
Reference Values
Turnaround Time
Results are available within 14 working days for up to 160 samples. For larger batches, please contact the laboratory team.
References
*) Accredited by KAN 17025:2017
For more information please contact:
lab@seameo-recfon.org
Description
Vitamin D is essential for proper bone and tooth formation and for maintaining calcium, phosphorus, and magnesium balance. In the blood, 25-hydroxyvitamin D [25(OH)D] is the major circulating form and the best biomarker for assessing vitamin D status because it is abundant, stable, and has a long half-life. It serves as the precursor to the biologically active hormone, 1,25-dihydroxyvitamin D. Vitamin D is obtained from sunlight (vitamin D3) and diet or supplements (vitamin D2 and D3). Both forms are converted in the liver and kidneys into the active hormone. Some assays measure total 25(OH)D, while others separately quantify D2 and D3.
Vitamin D deficiency leads to impaired mineralization, causing rickets in children and osteomalacia in adults. Beyond bone health, vitamin D influences immune function, cell growth, and may play roles in autoimmunity and cancer. Individuals at higher risk of deficiency include older adults, people with limited sun exposure, darker skin pigmentation, obesity, or chronic medication use.
Useful for
Method
Enzyme-Linked Immunosorbent Assay/ ELISA (MU.7.2.5)
Lower Limit of Quantitation (LLOQ): 3.95 ng/mL
Upper Limit of Quantitation (ULOQ): 116.78 ng/mL
Sample Requirements
Sample type:
Patient preparation:
Sample volume:
Sample Handling and Preparation
Sample stability:
Quality Control (QC)
Reference Values
The Endocrine Society, a global organization representing professionals from the field of endocrinology, defines vitamin D deficiency as 25(OH)D concentrations below 50 nmol/L 20 ng/mL) and vitamin D insufficiency as 52.0–72.5 nmol/L (21–29 ng/mL), based on multiple health outcomes, including but not limited to musculoskeletal outcomes. The European Food Safety Authority (EFSA) has suggested similar cutoff values.
References
*) Accredited by KAN 17025:2017
For more information please contact:
lab@seameo-recfon.org
Description
The Q-Plex Human Micronutrient v2 (7-Plex) is a multiplex chemiluminescent immunoassay designed for efficient assessment of micronutrient status in population-level surveillance. Micronutrient deficiencies disproportionately affect children and women of reproductive age, especially in low- and middle-income countries, and contribute to increased morbidity, mortality, and impaired developmental outcomes. This multiplex assay enables simultaneous measurement of seven key biomarkers—AGP, CRP, Ferritin, HRP2, RBP4, sTfR, and Thyroglobulin—in a single, low-volume sample, supporting large-scale surveys and program monitoring. Assay performance has been verified and calibrated with WHO/NIBSC international standards which improves confidence in data accuracy and reduces inter-laboratory bias.
Useful For
Method
Multiplex chemiluminescent immunoassay
| Analyte | Upper Limit if Quantitation (ULOQ) | Lower Limit of Quantitation (LLOQ) |
|---|---|---|
| AGP | 16.8 g/L | 0.02 g/L |
| CRP | 44.8 mg/L | 0.00384 mg/L |
| Ferritin | 1042.0 µg/L | 0.92 µg/L |
| sTfR | 152.8 mg/L | 0.168 mg/L |
| RBP4 | 42 µmol/L | 0.048 µmol/L |
| Thyroglobulin | 735.2 µg/L | 0.6 µg/L |
| HRP2 | 68 µg/L | 0.072 µg/L |
Sample Requirements
Sample type:
Sample volume:
Sample Handling and Preparation
Quality Control (QC)
Reference Values
Reference intervals depend on each analyte and should be interpreted using WHO, BRINDA, or survey-validated cut-offs.
Turnaround Time
Results are available within 14 working days for up to 150 samples. For larger batches, please contact the laboratory team.
References
For more information please contact:
lab@seameo-recfon.org
Description
Environmental Enteric Dysfunction (EED) is characterized by chronic intestinal inflammation, impaired barrier integrity, and reduced nutrient absorption. It is common in settings with high enteric pathogen exposure and inadequate sanitation. EED is associated with adverse outcomes including stunted growth, impaired cognitive development, reduced vaccine responsiveness, and increased susceptibility to infections such as pneumonia, acute diarrhea, and malaria.
The Q-Plex Human Environmental Enteric Dysfunction (11-Plex) assay provides a multiplex chemiluminescent platform to measure a comprehensive profile of biomarkers related to intestinal function, inflammation, nutrition, metabolic regulation, growth, and malaria exposure. The platform enables efficient, low-volume assessment suitable for population surveillance and research applications.
Useful For
Method
Multiplex chemiluminescent immunoassay
| Analyte | Upper Limit if Quantitation (ULOQ) | Lower Limit of Quantitation (LLOQ) |
|---|---|---|
| AGP | 2.7 g/L | 0.0041 g/L |
| CRP | 57.8 mg/L | 0.23 mg/L |
| Ferritin | 1284.4 µg/L | 1.3 µg/L |
| sTfR | 755.2 mg/L | 1.0 mg/L |
| RBP4 | 17.9 µmol/L | 0.025 µmol/L |
| Thyroglobulin | 128.0 µg/L | 0.18 µg/L |
| HRP2 | 9.7 µg/L | 0.036 µg/L |
| I-FABP | 21,526 pg/mL | 23.7 pg/mL |
| sCD14 | 25,352 ng/mL | 29.8 ng/mL |
| IGF-1 | 2,033.7 ng/mL | 3.2 ng/mL |
| FGF21 | 6,977.9 Pg/mL | 9.6 Pg/mL |
Sample Requirements
Sample type:
Sample volume:
Sample Handling and Preparation
Quality Control (QC)
Reference Values
Reference intervals depend on each analyte and should be interpreted using WHO, BRINDA, or survey-validated cut-offs.
Turnaround Time
Results are available within 14 working days for up to 150 samples. For larger batches, please contact the laboratory team.
References
For more information please contact:
lab@seameo-recfon.org
Description
Hematology analysis provides essential information on red blood cells, white blood cells, and platelets to support the assessment of anemia, infection, inflammation, and overall health status. For field-based research, capillary hemoglobin is measured a portable photometric device suitable for community or survey settings. For laboratory-based testing, a complete blood count (CBC) is performed using the hematology analyzer, which provides automated, high-precision quantitative parameters for clinical and research applications. These complementary methods allow flexible hematological assessment in both field and laboratory environments, supporting population surveys, nutrition programs, and clinical research studies.
Useful For
Method
Field Hemoglobin Measurement (HemoCue Hb 201+)
Complete Blood Count (CBC) – Sysmex XP-100
Sample Requirements
Sample types:
Sample volume:
Patient preparation:
Sample Handling and Preparation
Quality Control (QC)
Reference Values
Reference ranges vary by age, sex, and population. Commonly reported parameters include:
Turnaround Time
Field hemoglobin (HemoCue): Immediate (same day)
Laboratory CBC (Sysmex XP-100): 1–2 working days for routine batches
For large surveys, turnaround time can be adjusted based on sample volume—please contact the laboratory team.
References
For more information please contact:
lab@seameo-recfon.org
Jl. Utan Kayu Raya No.1A, RT.1/RW.8, Utan Kayu Utara, Kec. Matraman, Kota Jakarta Timur, Daerah Khusus Ibukota Jakarta 13120
+62-21 22116225
information@seameo-recfon.org